Deciphera Pharmaceuticals, Inc. (30)

Browse by Contract Category

Contracts

Employment Agreement, between Deciphera Pharmaceuticals, LLC and Stephen Ruddy (Filed With SEC on February 9, 2021)
Commercial Manufacturing Services and Supply Agreement, made as of April 3, 2019, by and between Deciphera Pharmaceuticals, LLC and Lonza (Filed With SEC on August 4, 2020)
Open Market Sale AgreementSM, dated August 4, 2020, by and between Deciphera Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on August 4, 2020)
Underwriting Agreement, dated February 13, 2020, by and among the Company, J.P. Morgan Securities LLC, Piper Sandler & Co. and Jefferies LLC (Filed With SEC on February 14, 2020)
License Agreement, made as of June 10, 2019, by and between Deciphera Pharmaceuticals, LLC and Zai Lab (Shanghai) Co., Ltd (Filed With SEC on August 2, 2019)
Third Amendment to Lease, dated April 29, 2019, by and between Deciphera Pharmaceuticals, Inc. and 200 Smith NWALP Property Owner LLC (Filed With SEC on May 3, 2019)
Amendment No. 1 to Employment Agreement, between Deciphera Pharmaceuticals, LLC and Daniel L. Flynn (Filed With SEC on February 9, 2021)
Employment Agreement, between Deciphera Pharmaceuticals, LLC and Daniel L. Flynn (Filed With SEC on February 9, 2021)
Amendment No. 1 to Employment Agreement, between Deciphera Pharmaceuticals, LLC and Thomas P. Kelly (Filed With SEC on February 9, 2021)
Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
Form of Restricted Stock Unit Award Agreement for Non-U.S. Grantees under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
Form of Non-Qualified Stock Option Agreement for Non-U.S. Optionees under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
Form of Restricted Stock Unit Award Agreement for Company Employees under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
Form of Non-Qualified Stock Option Agreement for Company Employees under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
Form of Incentive Stock Option Agreement under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
Amendment No. 1 to Employment Agreement, between Deciphera Pharmaceuticals, LLC and Thomas P. Kelly (Filed With SEC on August 4, 2020)
Supply Agreement, made as of February 28, 2020, by and between Deciphera Pharmaceuticals, LLC and Cambrex (Filed With SEC on August 4, 2020)
Deciphera Pharmaceuticals, Inc (Filed With SEC on May 5, 2020)
Letter Agreement, made as of January 17, 2020, by and between Deciphera Pharmaceuticals, LLC and Zai Lab (Shanghai) Co., Ltd (Filed With SEC on May 5, 2020)
Employment Agreement, between Deciphera Pharmaceuticals, LLC and Matthew L. Sherman (Filed With SEC on March 9, 2020)
Description of Securities (Filed With SEC on March 9, 2020)
Deciphera Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on November 4, 2019)
Underwriting Agreement, dated August 14, 2019, by and among the Company, J.P. Morgan Securities LLC, Piper Jaffray & Co. and Jefferies LLC (Filed With SEC on August 15, 2019)
Employment Agreement, between Deciphera Pharmaceuticals, LLC and Daniel C. Martin (Filed With SEC on March 14, 2019)
Amendment No. 2 dated December 17, 2018 to the Lease Agreement, dated May 29, 2018, by and between Deciphera Pharmaceuticals, Inc. and 200 Smith NWALP Property Owner LLC (Filed With SEC on March 14, 2019)
Amendment No. 1 dated October 26, 2018 to the Lease Agreement, dated May 29, 2018, by and between Deciphera Pharmaceuticals, Inc. and 200 Smith NWALP Property Owner LLC (Filed With SEC on March 14, 2019)
Employment Agreement, between Deciphera Pharmaceuticals, LLC and Thomas P. Kelly (Filed With SEC on March 14, 2019)
Employee Confidentiality, Assignment and Noncompetition Agreement, dated as of March 4, 2019, by and between Deciphera Pharmaceuticals, LLC and Steven Hoerter (Filed With SEC on March 4, 2019)
Employment Agreement, dated as of March 4, 2019, by and between Deciphera Pharmaceuticals, LLC and Steven Hoerter (Filed With SEC on March 4, 2019)
Transition Agreement, dated as of March 4, 2019, by and between Deciphera Pharmaceuticals, Inc., Deciphera Pharmaceuticals, LLC and Michael D. Taylor (Filed With SEC on March 4, 2019)